United Kingdom Organ-On-A-Chip Market Size, Share, and COVID-19 Impact Analysis, By Type (Service, Product, Instruments, and Others), By Application (Drug Discovery, Toxicology Research, and Others), and United Kingdom Organ-On-A-Chip Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Organ-On-A-Chip Market Insights Forecasts to 2035

• The United Kingdom Organ-On-A-Chip Market Size was estimated at USD 9.55 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 30.63% from 2025 to 2035
• The United Kingdom Organ-On-A-Chip Market Size is Expected to Reach USD 180.45 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United Kingdom Organ-On-A-Chip Market is anticipated to reach USD 180.45 million by 2035, growing at a CAGR of 30.63% from 2025 to 2035. The growing emphasis on precision healthcare and personalized treatment, along with developments in microfluidic technology, is anticipated to drive market expansion. Further factors that could drive the market during the projected period include increased research funding, industry-academia cooperation, and regulatory support for organ-on-a-chip (OOC) technology.

Market Overview

The United Kingdom organ-on-a-chip market refers to the business focused on the integration and application of microengineered devices that mimic the composition and functionality of human organs, constituting the core activities. Usually, microfluidic technology and living human cells are used to construct these chips, which replicate the physiological conditions of organs like the kidney, liver, heart, and lung. The chips are more like human physiology since they can sustain tissue-specific functions and control cell microenvironments. OoCs have garnered interest as a state-of-the-art experimental platform for researching human pathophysiology and the physiological impacts of treatments by fusing the most recent advancements in tissue engineering and microfabrication. In drug discovery, toxicity testing, disease modeling, and personalized medicine, OoC systems are being utilized more and more because they are made to more closely resemble actual human reactions than conventional cell cultures or animal models. The market consists of pharmaceutical businesses, biotechnology companies, university research, and regulatory agencies that want to improve the efficiency and reliability of preclinical testing while lowering the need for animal testing.

Report Coverage

This research report categorizes the market for the United Kingdom organ-on-a-chip market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom organ-on-a-chip market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom organ-on-a-chip market.

Driving Factors

The market for the United Kingdom organ-on-a-chip is driven by the regulatory encouragement and government backing, particularly in line with animal-free testing. Microphysiological systems are being actively promoted as acceptable preclinical models by the Medicines and Healthcare Products Regulatory Agency (MHRA) and other programs. Strong academic-industry partnerships that are driving innovation in personalized medicine, toxicology, and disease modeling. Furthermore, advances in biofabrication, integrated sensor technologies, and microfluidics, along with an increase in demand for personalized treatment platforms and predictive, human-relevant drug testing, support the UK's OoC growth. 3D bioprinting is an innovative approach that has enabled the creation of sophisticated organ structures for use in organ-on-a-chip models. The improvement in organ simulation accuracy brings researchers one step closer to accurately modeling human physiological reactions in a controlled environment.

Restraining Factors

Despite the substantial growth market face could be some hurdles such as the high upfront cost and complexity of development, manufacturing, the need for advanced fabrication methods, specific materials. Further market adoption and the shift from research to clinical or pharmaceutical usage by making it difficult for smaller businesses and academic institutions to extensively utilize the technology.

Market Segmentation

The United Kingdom organ-on-a-chip market share is classified into type and application.

• The product segment accounted for the highest market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.

The United Kingdom organ-on-a-chip market is segmented by type into service, product, instruments, and others. Among these, the product segment accounted for the highest market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. This is because of they can create more realistic models of human organs, organ on a chip (OOC) technology is transforming biomedical research. Chip helps with medication metabolism and toxicity research by simulating the function, and allows researchers to study by simulating function.

• The drug discovery segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The United Kingdom organ-on-a-chip market is segmented by application into drug discovery, toxicology research, and others. Among these, the drug discovery segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. This is because it is essential to the advancement of preclinical testing. OOC technology improves the precision and predictive value of drug testing by providing more physiologically appropriate models. Compared to conventional techniques, it allows researchers to more accurately evaluate medication efficacy, toxicity, and metabolism by simulating human organ functions in vitro.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom organ-on-a-chip market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Recent Developments:

• In February 2025, Queen Mary University of London formally unveiled one of the biggest and most sophisticated organ-on-a-chip facilities. The facility and its affiliated Centre for Doctoral Training, supported by a £7 million EPSRC investment and NC3Rs financing, intend to train future scientists 60 PhD students over the next eight years and expedite the creation of human-relevant chips to lessen the need for animal testing.

List Of Company

• CN Bio Innovations
• Cellesce Ltd 
• Diomite on a chip Research Groups
• Queen Mary Cente for predictive in vitro models

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom organ-on-a-chip market based on the below-mentioned segments:

United Kingdom Organ-on-a-Chip Market, By Type

• Service
• Product
• Instruments
• Others

United Kingdom Organ-on-a-Chip Market, By Application

• Drug Discovery
• Toxicology Research
• Others